HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nakamoto, Y. Articles by Wahl, R. L. Search for Related Content PubMed PubMed Citation Articles by Nakamoto, Y. Articles by Wahl, R. L.

Normal FDG Distribution Patterns in the Head and Neck: PET/CT Evaluation¹

¹ From the Division of Nuclear Medicine, Johns Hopkins University, 601 N Caroline St, Rm 3223A, Baltimore, MD 21287-0817. From the 2002 RSNA Annual Meeting. Received February 23, 2003; revision requested May 16; final revision received April 12, 2004; accepted May 26. R.L.W. supported by research grant from GE Medical Systems. Address correspondence to R.L.W. (e-mail: rwahl@jhmi.edu).

PURPOSE: To retrospectively evaluate the distribution of fluorine 18 fluorodeoxyglucose (FDG) in the head and neck region with combined positron emission tomography–computed tomography (PET/CT) in patients with no known abnormality in this region.

MATERIALS AND METHODS: The institutional review board allowed a retrospective review of PET/CT images obtained in 78 patients with non–head and neck cancer and waived the requirement for informed consent. The accumulation of FDG in 11 normal head and neck structures was visually and quantitatively assessed retrospectively. Positive rate percentage (PRP) was defined as the sum of the percentages of patients with grade 2 and grade 3 tracer uptake intensity. Standardized uptake values (SUVs) were calculated for quantitative analysis. Mean SUVs were compared between the male and female patients by using the unpaired t test, and the correlation between FDG uptake and patient age was assessed by using the Pearson correlation coefficient test.

RESULTS: Intense tracer uptake was usually seen in the palatine tonsils (PRP, 98%; mean SUV, 3.48), soft palate (PRP, 96%; mean SUV, 3.13), and lingual tonsils (PRP, 96%; mean SUV, 3.11). In the inferior concha (PRP, 4%; mean SUV, 1.56), thyroid gland (PRP, 3%; mean SUV, 1.31), and tongue (PRP, 1%; mean SUV, 1.39), uptake was typically minimal. FDG accumulation was variable in the sublingual glands (PRP, 72%; mean SUV, 2.93), spinal cord (PRP, 64%; mean SUV, 2.12), submandibular glands (PRP, 53%; mean SUV, 2.11), parotid glands (PRP, 51%; mean SUV, 1.90), and vocal cords (PRP, 19%; mean SUV, 1.77). The mean normal-tissue SUV in the soft palate was higher in male than in female patients (P < .01). A negative correlation between age and physiologic FDG uptake was seen in the palatine tonsils (r = –0.51, P < .001) and sublingual glands (r = –0.70, P < .001).

CONCLUSION: Intense FDG uptake was usually observed in the palatine tonsils, lingual tonsils, and soft palate, whereas uptake in the major salivary glands was variable.

© RSNA, 2005

This article has been cited by other articles:

				Y ARIJI, N FUWA, T KODAIRA, H TACHIBANA, T NAKAMURA, Y SATOH, and E ARIJI False-positive positron emission tomography appearance with 18F-fluorodeoxyglucose after definitive radiotherapy for cancer of the mobile tongue Br. J. Radiol., January 1, 2009; 82(973): e3 - e7. [Abstract] [Full Text] [PDF]

				M. Komissarova, K. K. Wong, M. Piert, S. K. Mukherji, and L. M. Fig Spectrum of 18F-FDG PET/CT Findings in Oncology-Related Recurrent Laryngeal Nerve Palsy Am. J. Roentgenol., January 1, 2009; 192(1): 288 - 294. [Abstract] [Full Text] [PDF]

				M. Comoretto, L. Balestreri, E. Borsatti, M. Cimitan, G. Franchin, and M. Lise Detection and Restaging of Residual and/or Recurrent Nasopharyngeal Carcinoma after Chemotherapy and Radiation Therapy: Comparison of MR Imaging and FDG PET/CT Radiology, October 1, 2008; 249(1): 203 - 211. [Abstract] [Full Text] [PDF]

				S. E. Finkelstein, P. W. Grigsby, B. A. Siegel, F. Dehdashti, J. F. Moley, and B. L. Hall Combined [18F]Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography (FDG-PET/CT) for Detection of Recurrent, 131I-Negative Thyroid Cancer Ann. Surg. Oncol., January 1, 2008; 15(1): 286 - 292. [Abstract] [Full Text] [PDF]

				D. Karantanis, T. V. Bogsrud, G. A. Wiseman, B. P. Mullan, R. M. Subramaniam, M. A. Nathan, P. J. Peller, R. S. Bahn, and V. J. Lowe Clinical Significance of Diffusely Increased 18F-FDG Uptake in the Thyroid Gland J. Nucl. Med., June 1, 2007; 48(6): 896 - 901. [Abstract] [Full Text] [PDF]

				J.-L. Roh, C. H. Ryu, S.-H. Choi, J. S. Kim, J. H. Lee, K.-J. Cho, S. Y. Nam, and S. Y. Kim Clinical Utility of 18F-FDG PET for Patients with Salivary Gland Malignancies J. Nucl. Med., February 1, 2007; 48(2): 240 - 246. [Abstract] [Full Text] [PDF]

				T. M. Blodgett, C. C. Meltzer, and D. W. Townsend PET/CT: Form and Function Radiology, February 1, 2007; 242(2): 360 - 385. [Abstract] [Full Text] [PDF]

				Y.-K. Chen, C.-T. Su, K.-H. Chi, R.-H. Cheng, S.-C. Wang, and C.-H. Hsu Utility of 18F-FDG PET/CT Uptake Patterns in Waldeyer's Ring for Differentiating Benign from Malignant Lesions in Lateral Pharyngeal Recess of Nasopharynx J. Nucl. Med., January 1, 2007; 48(1): 8 - 14. [Abstract] [Full Text] [PDF]

				N. Subhas, P. V. Patel, H. K. Pannu, H. A. Jacene, E. K. Fishman, and R. L. Wahl Imaging of Pelvic Malignancies with In-Line FDG PET-CT: Case Examples and Common Pitfalls of FDG PET RadioGraphics, July 1, 2005; 25(4): 1031 - 1043. [Abstract] [Full Text] [PDF]